| GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Patients with Type 2 Diabetes. (NCT06017544) | University of Campania Luigi Vanvitelli | 2017-01-01 |
| CArdioMetabolism and Atherosclerotic PlaqUe progreSsion (NCT05117424) | Ruijin Hospital | 2017-01-01 |
| Empagliflozin-based Quadruple Combination vs Insulin Glarine-based Combination Therapy in Patients With Type 2 Diabetes (NCT03473262) | Chungbuk National University Hospital | 2017-01-01 |
| Empagliflozin-based Quadruple Therapy vs Basal Insulin-based Therapy (NCT05103306) | Chungbuk National University Hospital | 2017-01-01 |
| Stromal Vascular Fraction and Autologous Activated Platelet-Rich Plasma Combination in Treating Treatment of Type 2 Diabetes (NCT05925829) | Hayandra Peduli Foundation | 2017-01-01 |
| Assessment of Dapagliflozin Effect on Diabetic Endothelial Dysfunction of Brachial Artery (NCT02919345) | University of Campinas, Brazil | 2017-01-01 |
| Non-Interventional Study of the Use of Alogliptin and Alogliptin Fixed-Dose Combinations With Pioglitazone and With Metformin in Standard Clinical Practice (NCT02989649) | Takeda | 2016-12-22 |
| A Study of LY3209590 in Healthy Participants and Participants With Type 2 Diabetes (NCT02942914) | Eli Lilly and Company | 2016-12-20 |
| Effect of Farxiga on Renal Function and Size in Type 2 Diabetic Patients With Hyperfiltration (NCT02911792) | The University of Texas Health Science Center at San Antonio | 2016-12-20 |
| Evaluation of Non - Surgical Periodontal Therapy in Diabetic Patients. (NCT03764410) | Universidade Metropolitana de Santos | 2016-12-20 |
| The Effects of an Intensive Lifestyle Intervention for Type 2 Diabetes on Disability Insurance (NCT04515745) | University of Minnesota | 2016-12-19 |
| Study to Asses the Effect of Dapagliflozin on Central Blood Pressure Reduction. (NCT02919059) | IInstituto Gallego de Medicina Vascular | 2016-12-13 |
| Effects of Low Intensity Therapeutic Ultrasound on Endothelial Function (NCT02872922) | Universidade Federal de Santa Maria | 2016-12-10 |
| Chronotype of Patients With Diabetes and Effect on Glycaemic Control (NCT02973412) | University of Leicester | 2016-12-07 |
| SGLT-2 Inhibitor Empagliflozin Effects on Appetite and Weight Regulation. (NCT02798744) | University of Leicester | 2016-12-01 |
| Empa PASS on Urinary Tract Malignancies (NCT03464045) | Boehringer Ingelheim | 2016-11-16 |
| A Trial Investigating the Safety, Tolerability, Pharmacokinetics (the Exposure of the Trial Drug in the Body) and Pharmacodynamics (the Effect of the Investigated Drug on the Body) of Insulin 287 in Subjects With Type 2 Diabetes (NCT02964104) | Novo Nordisk A/S | 2016-11-15 |
| Isomaltulose VS Sucrose - Postprandial Effect on Incretin Profile and Second Meal Effect (NCT03806920) | German Institute of Human Nutrition | 2016-11-05 |
| Using Mobile Phone Short Message Service (SMS) Reminders to Enhance Appointment Attendance in DM Patients (NCT03055702) | The University of Hong Kong | 2016-11-01 |
| Diabetic Artery Obstruction: is it Possible to Reduce Ischemic Events With Cilostazol? (NCT02983214) | University of Ioannina | 2016-11-01 |
| Epigenetics of Muscle Insulin Resistance (NCT03259984) | University of Arizona | 2016-11-01 |
| The Effect Effect of Empagliflozin on Oxidative Stress in Patients With Type 2 Diabetes (NCT02890745) | Henrik Enghusen Poulsen | 2016-11-01 |
| HbA1c Variability in Type II Diabetes (NCT02879409) | Weill Cornell Medical College in Qatar | 2016-11-01 |
| ENhancing Outcomes Through Goal Assessment and Generating Engagement in Diabetes Mellitus (NCT02910089) | AstraZeneca | 2016-10-20 |
| A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 2 Diabetes Mellitus (NCT02933853) | Novo Nordisk A/S | 2016-10-14 |
| Phase 3 Alogliptin Pediatric Study (NCT02856113) | Takeda | 2016-10-14 |
| Effects of Empagliflozin on Left Ventricular Diastolic Function Compared to Usual Care in Type 2 Diabetics (NCT02932436) | Johannes Gutenberg University Mainz | 2016-10-10 |
| GLP1-imaging Before and After Bariatric Surgery (NCT03182231) | Radboud University Medical Center | 2016-10-07 |
| Extension to Study 200952 to Evaluate the Long-term Safety, Tolerability and Pharmacodynamics of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus Subjects (NCT02750930) | GlaxoSmithKline | 2016-10-07 |
| Short-term Effects of Perindopril-amlodipine Versus Perindopril-indapamide in Type 2 Diabetes (NCT03747978) | Yaounde Central Hospital | 2016-10-01 |
| The Effects of Metformin on Self-selected Exercise Intensity, Physical Fitness and Exercise-induced AMPK-activation (NCT02951260) | Rigshospitalet, Denmark | 2016-10-01 |
| PROTOCOL 3: Role of the Renal Nerves in the Increase in EGP in Response to Glucosuria (NCT03168295) | The University of Texas Health Science Center at San Antonio | 2016-10-01 |
| Treatment of Diabetes in Patients With Systolic Heart Failure (NCT02920918) | Virginia Commonwealth University | 2016-10-01 |
| Cardiorespiratory Parameters and Glycated Hemoglobin of Patients With Type 2 Diabetes After a Rehabilitation Program (NCT03094767) | União Educacional do Norte | 2016-10-01 |
| Enhancing Self-Management Support in Diabetes Through Patient Engagement (NCT02834923) | University of California, San Francisco | 2016-10-01 |
| Effect of Anti-diabetic Drugs on Glycemic Variability (NCT02925559) | Centro de Diabetes Curitiba Ltda | 2016-10-01 |
| Linagliptin Add-on to Insulin Background Therapy (NCT02897349) | Boehringer Ingelheim | 2016-09-30 |
| Effect of Escalating Oral Vitamin D Replacement on HOMA-IR in Vitamin D Deficient Type 2 Diabetics (NCT04183257) | King Edward Medical University | 2016-09-30 |
| Salud y Vida 2.0: Enhancing Integrated Behavioral Health for Diabetics in the Rio Grande Valley (NCT04035395) | The University of Texas Health Science Center, Houston | 2016-09-29 |
| An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus Subjects (NCT02793154) | GlaxoSmithKline | 2016-09-26 |
| A Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal or Pre-mix/Combination Insulin Therapy and Oral Anti-diabetic Drugs (NCT02911948) | Novo Nordisk A/S | 2016-09-21 |
| A 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment Intensification (NCT02906917) | Novo Nordisk A/S | 2016-09-20 |
| Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise Only (NCT02906930) | Novo Nordisk A/S | 2016-09-20 |
| Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus. (NCT02849080) | Novo Nordisk A/S | 2016-09-20 |
| Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment (NCT02827708) | Novo Nordisk A/S | 2016-09-20 |
| Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) (NCT02836704) | Sanofi | 2016-09-09 |
| Adaptation of a Cognitive Training Intervention for Diabetes Self-Management (NCT03221452) | University of Texas at Austin | 2016-09-02 |
| Formulas for Diabetes With Sucromalt & Isomaltulose on Glycemic Index, Hormones & Subjective Appetite in Type 2 Diabetes (NCT03829800) | Universidad del Zulia | 2016-09-01 |
| A Phase 2 Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Stable Type 2 Diabetes and Hypertension (NCT02906579) | Cyclerion Therapeutics | 2016-09-01 |
| Effect of FISH Intake on MEtabolic Health in a Diabetic South Asian popuLation (FISH MEAL) (NCT02840630) | University of Aberdeen | 2016-09-01 |
| Liraglutide for HIV-associated Neurocognitive Disorder (NCT02743598) | Temple University | 2016-09-01 |
| Genetics of Response to Canagliflozin (NCT02891954) | University of Maryland, Baltimore | 2016-09-01 |
| Translation, Cultural Adaptation and Validation of the Creole Versions of the EQ-5D and the SF-36 Questionnaires in Patients With Type II Diabetes in Reunion Island, Martinique and Guadeloupe (NCT02898493) | Centre Hospitalier Universitaire de la Réunion | 2016-09-01 |
| QUANtification of Cardiovascular Autonomic Neuropathy (CAN) and the Effects of Anaesthesia on Haemodynamics and Cerebral Perfusion (NCT03071432) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2016-08-30 |
| Economic Outcomes of EQW (Exenatide Once Weekly) vs. IG (Insulin Glargine) in T2D Patients Who Are New to Injectable Therapy (NCT02843399) | AstraZeneca | 2016-08-15 |
| Efficacy and Safety of Oral Semaglutide Versus Empagliflozin in Subjects With Type 2 Diabetes Mellitus (NCT02863328) | Novo Nordisk A/S | 2016-08-10 |
| Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus (NCT02863419) | Novo Nordisk A/S | 2016-08-10 |
| JARDIANCE Regulartory Post Marketing Surveillance in Korean Type 2 Diabetes Mellitus (NCT02848833) | Boehringer Ingelheim | 2016-08-10 |
| Mobile Exergaming in Type 2 Diabetes (NCT02657018) | University of Basel | 2016-08-01 |
| Metabolomic Profiling of in Patients With type2 Diabetes (NCT03725709) | Chang Gung Memorial Hospital | 2016-08-01 |
| Gastric Ultrasound of Diabetic and Non-Diabetic Patients Following Preoperative Fasting Instructions (NCT02888951) | University Health Network, Toronto | 2016-08-01 |
| Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-64565111 in Type 2 Diabetes Mellitus (T2DM) (NCT02862431) | Janssen Research & Development, LLC | 2016-07-12 |
| Evaluation of Lixisenatide Efficacy in Diabetes Mellitus Type 2 With Failure of Other GLP-1 Analog (NCT02767596) | Laniado Hospital | 2016-07-12 |
| Effects of SGLT2 Inhibitor on Hemodynamic Parameters in Resistant Hypertensive Subjects (NCT03089333) | University of Campinas, Brazil | 2016-07-01 |
| Physical Activity Behavior Change for Older Adults After Dysvascular Amputation (NCT02738086) | VA Office of Research and Development | 2016-07-01 |
| Canagliflozin (Invokana™) vs. Standard Dual Therapy Regimen for T2DM During Ramadan (NCT02694263) | University of Leicester | 2016-07-01 |
| Effect of DapagliFLOzin on Quality of Life in Patients With Type 2 Diabetes in a Real Clinical PrActice (NCT02719132) | AstraZeneca | 2016-07-01 |
| School-Based Program On Metabolic Disease (NCT03768245) | Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado | 2016-07-01 |
| Integrative Care for Type 2 Diabetes (NCT02843724) | The Canadian College of Naturopathic Medicine | 2016-07-01 |
| Serum Sphingolipidomic Analyses in Healthy, Diabetic and Prediabetic Subjects (NCT02826759) | First Affiliated Hospital Xi'an Jiaotong University | 2016-07-01 |
| Effect of Roux-en-Y Gastric Bypass or Gastric Sleeve Surgery on Type 2 Diabetes (NCT02713555) | University of Aarhus | 2016-07-01 |
| SGLT2 Inhibition in Diabetes and Heart Failure (NCT02862067) | Virginia Commonwealth University | 2016-07-01 |
| A Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Ethinylestradiol and Levonorgestrel in an Oral Contraceptive Combination Drug in Healthy Postmenopausal Females (NCT02845219) | Novo Nordisk A/S | 2016-07-01 |
| Low dosE GlibENclamide in Diabetes Part A (NCT02830048) | University of Oxford | 2016-07-01 |
| Feasibility Study on the Impact of Economic Incentives to Improve the Management of Type 2 Diabetes Mellitus (NCT02891382) | Universidad Peruana Cayetano Heredia | 2016-07-01 |
| Dapagliflozin Patient Satisfaction Survey (NCT02805283) | AstraZeneca | 2016-06-22 |
| The T2D Profile - Studies of the Omics Profile in Type 2 Diabetes (NCT06905717) | Göteborg University | 2016-06-15 |
| A Trial Investigating the Effect of Oral Semaglutide Compared With Placebo on Postprandial Glucose and Triglyceride Metabolism, Energy Intake, Appetite Sensations and Gastric Emptying in Subjects With Type 2 Diabetes (NCT02773381) | Novo Nordisk A/S | 2016-06-02 |
| Lifestyle Intervention for Adults With Diabetes (NCT02699307) | University of Michigan | 2016-06-01 |
| A Randomized, Placebo-controlled, Double Blind Trial to Investigate Whether Vitamin K2 Can Influence Arterial Calcification in Patients With Type 2 Diabetes (NCT02839044) | UMC Utrecht | 2016-06-01 |
| Effect of Evogliptin on Bone Metabolism in Human (NCT02587975) | DongGuk University | 2016-06-01 |
| Platelet Inhibition of Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients After Elective Percutaneous Coronary Intervention (NCT02748330) | Peking Union Medical College Hospital | 2016-06-01 |
| Efficacy of Exenatide-LAR and Dapagliflozin in Overweight/Obese, Insulin Treated Patients With Type 2 Diabetes (NCT02811484) | Weill Medical College of Cornell University | 2016-06-01 |
| The Effect of DPP4 Inhibitor on Vasclular Healing (NCT02802644) | Chung-Ang University | 2016-06-01 |
| Dietary Polyphenols and Glycation in Renal Insufficiency (NCT02524938) | NHS Greater Glasgow and Clyde | 2016-06-01 |
| The Effect of Acipimox on GLP (Glucagon-like Peptide)-1 Secretion (NCT02796950) | University of Aarhus | 2016-06-01 |
| Improving Medication Adherence Among Underserved Patients With Type 2 Diabetes (NCT02409329) | Vanderbilt University Medical Center | 2016-05-23 |
| FAMS Mobile Health Intervention for Diabetes Self-care Support (NCT02481596) | Vanderbilt University Medical Center | 2016-05-23 |
| A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes Mellitus (NCT02773368) | Novo Nordisk A/S | 2016-05-23 |
| Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor Agonist (NCT02738151) | Sanofi | 2016-05-19 |
| An Extension Study of PEAK Trial (NCT02763007) | Kun-Ho Yoon | 2016-05-18 |
| Shared Medical Visits for Spanish-speaking Patients With Type 2 Diabetes (NCT02836015) | University of Nebraska | 2016-05-13 |
| Cardiovascular Outcomes in Participants With Type 2 Diabetes Mellitus (T2DM) (NCT03249506) | Janssen Research & Development, LLC | 2016-05-12 |
| The Effect of Iloprost on Capillary Recruitment and Insulin Sensitivity in Type 2 Diabetes (NCT03380325) | Amsterdam UMC, location VUmc | 2016-05-11 |
| Empagliflozin and ACEi- Effects on Hyperfiltration: BETWEEN Study (NCT02632747) | Boehringer Ingelheim | 2016-05-10 |
| Effectiveness of a Case Management Model for Patients With Hypertension and Type II Diabetes in Chile (NCT02762695) | Pontificia Universidad Catolica de Chile | 2016-05-04 |
| Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Subjects With Type 2 Diabetes (NCT02762578) | Novo Nordisk A/S | 2016-05-03 |
| Dapagliflozin and Cholesterol Metabolism in Type 2 Diabetes (DM2) (NCT03074630) | Amsterdam UMC, location VUmc | 2016-05-01 |
| Effectiveness of Motivational Interviewing on Improving Care for Patients With Type 2 Diabetes in China (NCT04342845) | The University of Hong Kong | 2016-05-01 |
| Reaching Better Health Study: A Website to Improve Type 2 Diabetes Self-Management (NCT02757937) | Children's Hospital of Philadelphia | 2016-05-01 |